|
|
|
|||||||
|
|||||||||
(Received for publication, July 17, 1997)
From the Malignant hyperthermia (MH) and central
core disease (CCD) are autosomal dominant disorders of skeletal muscle
in which a potentially fatal hypermetabolic crisis can be triggered by
commonly used anesthetic agents. To date, 17 mutations in the human
RYR1 gene encoding the Ca2+ release channel of
skeletal muscle sarcoplasmic reticulum (the ryanodine receptor) have
been associated with MH and/or CCD. Although many of these mutations
have been linked to MH and/or CCD, with high lod (log of the odds
favoring linkage versus nonlinkage) scores, others have been found in
single, small families. Independent biochemical evidence for a causal
role for these mutations in MH is available for only two mutants.
Mutations corresponding to the human MH mutations were made in a
full-length rabbit RYR1 cDNA, and wild type and mutant
cDNAs were transfected into HEK-293 cells. After about 48 h,
intact cells were loaded with the fluorescent Ca2+
indicator, fura-2, and intracellular Ca2+ release, induced
by caffeine or halothane, was measured by photometry. Ca2+
release in cells expressing MH or CCD mutant ryanodine receptors was
invariably significantly more sensitive to low concentrations of
caffeine and halothane than Ca2+ release in cells
expressing wild type receptors or receptors mutated in other regions of
the molecule. Linear regression analysis showed that there is a strong
correlation (r = 0.95, p < 0.001) between caffeine sensitivity of different RYR1 mutants
measured by the cellular Ca2+ photometry assay and by the
clinical in vitro caffeine halothane contracture test
(IVCT). The correlation was weaker, however, for halothane
(r = 0.49, p > 0.05). Abnormal
sensitivity in the Ca2+ photometry assay provides
supporting evidence for a causal role in MH for each of 15 single amino
acid mutations in the ryanodine receptor. The study demonstrates the
usefulness of the cellular Ca2+ photometry assay in the
assessment of the sensitivity to caffeine and halothane of specific
ryanodine receptor mutants.
Volume 272, Number 42,
Issue of October 17, 1997
pp. 26332-26339
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Caffeine and Halothane Sensitivity of Intracellular
Ca2+ Release Is Altered by 15 Calcium Release Channel
(Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia
and/or Central Core Disease
§
,
,
and§
Banting and Best Department of Medical
Research, University of Toronto, Charles H. Best Institute, Toronto,
Ontario M5G 1L6, Canada, the § Department of Biochemistry,
University of Toronto, Medical Sciences Building, Toronto, Ontario M6S
1A1, Canada, the ** Division of Cell Biology, The Research Institute,
Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, and the
Department of Biochemistry, University
College, Cork, Ireland
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Girard, M. Suhner, S. Levano, M. Singer, A. Zollinger, and C. K. Hofer A Fulminant Malignant Hyperthermia Episode in a Patient with Ryanodine Receptor Gene Mutation p.Tyr522Ser Anesth. Analg., December 1, 2008; 107(6): 1953 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jiang, W. Chen, J. Xiao, R. Wang, H. Kong, P. P. Jones, L. Zhang, B. Fruen, and S. R. W. Chen Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia J. Biol. Chem., July 25, 2008; 283(30): 20813 - 20820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Meng, B. Xiao, S. Cai, X. Huang, F. Li, J. Bolstad, R. Trujillo, J. Airey, S. R. W. Chen, T. Wagenknecht, et al. Three-Dimensional Localization of Serine 2808, a Phosphorylation Site in Cardiac Ryanodine Receptor J. Biol. Chem., August 31, 2007; 282(35): 25929 - 25939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Aracena-Parks, S. A. Goonasekera, C. P. Gilman, R. T. Dirksen, C. Hidalgo, and S. L. Hamilton Identification of Cysteines Involved in S-Nitrosylation, S-Glutathionylation, and Oxidation to Disulfides in Ryanodine Receptor Type 1 J. Biol. Chem., December 29, 2006; 281(52): 40354 - 40368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Duke, P. M. Hopkins, P. J. Halsall, and D. S. Steele Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia Br. J. Anaesth., September 1, 2006; 97(3): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations J. Biol. Chem., April 15, 2005; 280(15): 15380 - 15389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Lopez, N. Linares, I. N. Pessah, and P. D. Allen Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i Am J Physiol Cell Physiol, March 1, 2005; 288(3): C606 - C612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Weiss, K. M. S. O'Connell, B. E. Flucher, P. D. Allen, M. Grabner, and R. T. Dirksen Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1094 - C1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du, G. Avila, P. Sharma, V. K. Khanna, R. T. Dirksen, and D. H. MacLennan Role of the Sequence Surrounding Predicted Transmembrane Helix M4 in Membrane Association and Function of the Ca2+ Release Channel of Skeletal Muscle Sarcoplasmic Reticulum (Ryanodine Receptor Isoform 1) J. Biol. Chem., September 3, 2004; 279(36): 37566 - 37574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Gallant, J. Hart, K. Eager, S. Curtis, and A. F. Dulhunty Caffeine sensitivity of native RyR channels from normal and malignant hyperthermic pigs: effects of a DHPR II-III loop peptide Am J Physiol Cell Physiol, April 1, 2004; 286(4): C821 - C830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Shepherd, F Ellis, J Halsall, P Hopkins, and R Robinson RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene J. Med. Genet., March 1, 2004; 41(3): e33 - 33. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Papadimos, M. Almasri, J. C. Padgett, and J. E. Rush A Suspected Case of Delayed Onset Malignant Hyperthermia with Desflurane Anesthesia Anesth. Analg., February 1, 2004; 98(2): 548 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Glover, J. J. A. Heffron, and K. Ohlendieck Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle J Appl Physiol, January 1, 2004; 96(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guis, D. Figarella-Branger, N. Monnier, D. Bendahan, G. Kozak-Ribbens, J.-P. Mattei, J. Lunardi, P. J. Cozzone, and J.-F. Pellissier Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia: Histology, In Vitro Contracture Tests, and Genetic Characterization Arch Neurol, January 1, 2004; 61(1): 106 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Perez, S. Mukherjee, and P. D. Allen Amino Acids 1-1,680 of Ryanodine Receptor Type 1 Hold Critical Determinants of Skeletal Type for Excitation-Contraction Coupling: ROLE OF DIVERGENCE DOMAIN D2 J. Biol. Chem., October 10, 2003; 278(41): 39644 - 39652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Terada, I. Muraoka, and I. Tabata Changes in [Ca2+]i induced by several glucose transport-enhancing stimuli in rat epitrochlearis muscle J Appl Physiol, May 1, 2003; 94(5): 1813 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Avila, K. M. S. O'Connell, and R. T. Dirksen The Pore Region of the Skeletal Muscle Ryanodine Receptor Is a Primary Locus for Excitation-Contraction Uncoupling in Central Core Disease J. Gen. Physiol., March 31, 2003; 121(4): 277 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tong, S. Elowe, P. Nash, and T. Pawson Manipulation of EphB2 Regulatory Motifs and SH2 Binding Sites Switches MAPK Signaling and Biological Activity J. Biol. Chem., February 14, 2003; 278(8): 6111 - 6119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Du, B. Sandhu, V. K. Khanna, X. H. Guo, and D. H. MacLennan Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1) PNAS, December 24, 2002; 99(26): 16725 - 16730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Girard, S. Treves, K. Censier, C. R. Mueller, F. Zorzato, and A. Urwyler Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells Br. J. Anaesth., October 1, 2002; 89(4): 571 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.D. Allen Leaky "Feet" and Sudden Death Circ. Res., August 9, 2002; 91(3): 181 - 182. [Full Text] [PDF]
|
|
|
|
|
|
D. Jiang, B. Xiao, L. Zhang, and S.R. W. Chen Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated With Ventricular Tachycardia and Sudden Death Circ. Res., August 9, 2002; 91(3): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Davis, R. Brown, A. Dickson, H. Horton, D. James, N. Laing, R. Marston, M. Norgate, D. Perlman, N. Pollock, et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees Br. J. Anaesth., April 1, 2002; 88(4): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brooks, R. L. Robinson, P. J. Halsall, and P. M. Hopkins No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population{dagger} Br. J. Anaesth., April 1, 2002; 88(4): 587 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tilgen, F. Zorzato, B. Halliger-Keller, F. Muntoni, C. Sewry, L. M. Palmucci, C. Schneider, E. Hauser, F. Lehmann-Horn, C. R. Muller, et al. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis Hum. Mol. Genet., December 1, 2001; 10(25): 2879 - 2887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Monnier, N. B. Romero, J. Lerale, P. Landrieu, Y. Nivoche, M. Fardeau, and J. Lunardi Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor Hum. Mol. Genet., October 1, 2001; 10(22): 2581 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rueffert, D. Olthoff, C. Deutrich, B. Thamm, and U. G. Froster Homozygous and heterozygous Arg614Cys mutations (1840C{->}T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family Br. J. Anaesth., August 1, 2001; 87(2): 240 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Lamb, G. S. Posterino, T. Yamamoto, and N. Ikemoto Effects of a domain peptide of the ryanodine receptor on Ca2+ release in skinned skeletal muscle fibers Am J Physiol Cell Physiol, July 1, 2001; 281(1): C207 - C214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Avila, J. J. O'Brien, and R. T. Dirksen Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor PNAS, March 27, 2001; 98(7): 4215 - 4220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Robinson and P. M. Hopkins Editorial III: A breakthrough in the genetic diagnosis of malignant hyperthermia Br. J. Anaesth., February 1, 2001; 86(2): 166 - 168. [Full Text] [PDF]
|
|
|
|
|
|
A. Urwyler, T. Deufel, T. McCarthy, and S. West Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia{{dagger}} Br. J. Anaesth., February 1, 2001; 86(2): 283 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Winberg, L. Matskova, F. Chen, P. Plant, D. Rotin, G. Gish, R. Ingham, I. Ernberg, and T. Pawson Latent Membrane Protein 2A of Epstein-Barr Virus Binds WW Domain E3 Protein-Ubiquitin Ligases That Ubiquitinate B-Cell Tyrosine Kinases Mol. Cell. Biol., November 15, 2000; 20(22): 8526 - 8535. [Abstract] [Full Text]
|
|
|
|
|
|
N. Monnier, N. B. Romero, J. Lerale, Y. Nivoche, D. Qi, D. H. MacLennan, M. Fardeau, and J. Lunardi An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor Hum. Mol. Genet., November 1, 2000; 9(18): 2599 - 2608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Dietze, J Henke, H M Eichinger, F Lehmann-Horn, and W Melzer Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release J. Physiol., August 1, 2000; 526(3): 507 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Hopkins Malignant hyperthermia: advances in clinical management and diagnosis Br. J. Anaesth., July 1, 2000; 85(1): 118 - 128. [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du, V. K. Khanna, and D. H. MacLennan Mutation of Divergent Region 1 Alters Caffeine and Ca2+ Sensitivity of the Skeletal Muscle Ca2+ Release Channel (Ryanodine Receptor) J. Biol. Chem., April 14, 2000; 275(16): 11778 - 11783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. El-Hayek, Y. Saiki, T. Yamamoto, and N. Ikemoto A Postulated Role of the Near Amino-terminal Domain of the Ryanodine Receptor in the Regulation of the Sarcoplasmic Reticulum Ca2+ Channel J. Biol. Chem., November 19, 1999; 274(47): 33341 - 33347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lehmann-Horn and K. Jurkat-Rott Voltage-Gated Ion Channels and Hereditary Disease Physiol Rev, October 1, 1999; 79(4): 1317 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du and D. H. MacLennan Ca2+ Inactivation Sites Are Located in the COOH-terminal Quarter of Recombinant Rabbit Skeletal Muscle Ca2+ Release Channels (Ryanodine Receptors) J. Biol. Chem., September 10, 1999; 274(37): 26120 - 26126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murayama, T. Oba, E. Katayama, H. Oyamada, K. Oguchi, M. Kobayashi, K. Otsuka, and Y. Ogawa Further Characterization of the Type 3 Ryanodine Receptor (RyR3) Purified from Rabbit Diaphragm J. Biol. Chem., June 11, 1999; 274(24): 17297 - 17308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lynch, J. Tong, M. Lehane, A. Mallet, L. Giblin, J. J. A. Heffron, P. Vaughan, G. Zafra, D. H. MacLennan, and T. V. McCarthy A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease PNAS, March 30, 1999; 96(7): 4164 - 4169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Barone, O. Massa, E. Intravaia, A. Bracco, A. Di Martino, V. Tegazzin, S. Cozzolino, and V. Sorrentino Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families J. Med. Genet., February 1, 1999; 36(2): 115 - 118. [Abstract] [Full Text]
|
|
|
|
|
|
J. Tong, T. V. McCarthy, and D. H. MacLennan Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels J. Biol. Chem., January 8, 1999; 274(2): 693 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du, J. P. Imredy, and D. H. MacLennan Characterization of Recombinant Rabbit Cardiac and Skeletal Muscle Ca2+ Release Channels (Ryanodine Receptors) with a Novel [3H]Ryanodine Binding Assay J. Biol. Chem., December 11, 1998; 273(50): 33259 - 33266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du and D. H. MacLennan Functional Consequences of Mutations of Conserved, Polar Amino Acids in Transmembrane Sequences of the Ca2+ Release Channel (Ryanodine Receptor) of Rabbit Skeletal Muscle Sarcoplasmic Reticulum J. Biol. Chem., November 27, 1998; 273(48): 31867 - 31872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leong and D. H. MacLennan The Cytoplasmic Loops between Domains II and III and Domains III and IV in the Skeletal Muscle Dihydropyridine Receptor Bind to a Contiguous Site in the Skeletal Muscle Ryanodine Receptor J. Biol. Chem., November 6, 1998; 273(45): 29958 - 29964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zhao, P. Li, S. R. W. Chen, C. F. Louis, and B. R. Fruen Dantrolene Inhibition of Ryanodine Receptor Ca2+ Release Channels. MOLECULAR MECHANISM AND ISOFORM SELECTIVITY J. Biol. Chem., April 20, 2001; 276(17): 13810 - 13816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan Functional Characterization of Mutants in the Predicted Pore Region of the Rabbit Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor Isoform 2) J. Biol. Chem., August 17, 2001; 276(34): 31760 - 31771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tong, M. Killeen, R. Steven, K. L. Binns, J. Culotti, and T. Pawson Netrin Stimulates Tyrosine Phosphorylation of the UNC-5 Family of Netrin Receptors and Induces Shp2 Binding to the RCM Cytodomain J. Biol. Chem., October 26, 2001; 276(44): 40917 - 40925. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |